The Global Tissue Imaging Market size was valued at USD 10.3 billion in 2023 and is projected to reach USD 14.3 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9.50% during the forecast period, i.e., 2024-30.

Access Free Sample Report https://www.marknteladvisors.com/query/request-sample/global-tissue-imaging-market.html         

Key Findings of the Study: Tissue Imaging Market

Global Tissue Imaging Market Driver: Inclination Towards Precision Medicine to Drive the Global Tissue Imaging Market

Globally, the cases of cancer & neurological diseases are on the rise. However, current treatment methods, based on a one-size-fits-all approach, have not been very effective or beneficial to every patient suffering from these conditions. In addition, certain treatments have had negative impacts on the patients' health.

As a result, the focus has shifted to the research and development of therapies tailored to the patient’s genetics, environment, and lifestyle factors. These have greater efficacy, benefits, and minimal side effects than conventional treatments. This shifted focus has led to the adoption of tissue imaging technologies, which provide researchers with detailed visualizations and analyses of cellular and molecular structures. The information enables them to develop effective personalized treatments.

Furthermore, increased investments and funding by governments of different nations and private pharmaceutical companies to encourage research on personalized medicine have propelled the adoption of tissue imaging techniques. As a result, the market size for Tissue Imaging has been expanding globally.

Scope of the Report and Tissue Imaging Market Segmentation

By Technology

-Mass Spectroscopy

--MALDI Imaging

--DESI Imaging

--SIMS Imaging

-Immunohistochemistry (IHC)

-Flow Cytometry

-Digital Pathology

-In Situ Hybridization (ISH)

--Fluorescence In-Situ Hybridization (FISH)

---DNA Fluorescence In-Situ Hybridization

---RNA Fluorescence In-Situ Hybridization

---Protein Fluorescence In-Situ Hybridization

---Chromogenic In-Situ Hybridization (CISH)

-Immunofluorescence

--Indirect Immunofluorescence (Secondary)

--Direct Immunofluorescence (Primary)

-Others (Confocal Microscopy, Electron Microscopy, etc.)

• The Flow Cytometry segment had a considerable market share in the Global Tissue Imaging Market in 2023.

By Component

-Platforms

--Mass Spectroscopy Imaging (MSI) Platforms

--Flow Cytometry Analyzers

--Digital Pathology Scanners

--Immunohistochemistry Detection Systems

--In-Situ Hybridization Platforms

--Immunofluorescence Imaging Analysis Systems

--Tissue Microarray Platforms

--Others (Quantitative PCR Systems, Microscopy Accessories, etc.)

-Microscopes

--Optical Microscopes

---Compound Microscopes

---Digital Microscopes

---Fluorescence Microscopes

---Others (Polarizing Microscopes, Phase Contrast Microscopes, etc.)

--Electron Microscopes

---Scanning Electron Microscopes (SEM)

---Transmission Electron Microscopes (TEM)

--Scanning Probe Microscopes

--Others (Field Emission Scanning Electron Microscopes (FESEM), Low-Voltage Scanning Electron Microscopes (LVSEM), etc.)

-Consumables

--Antibodies & Reagents

--Kits

--Probes

--Others (Buffers and Salts, Substrates, etc.)

-Software

-Accessories

By Therapeutic Application

-By Disease Research

--Oncology Research

--Infectious Diseases Research

--Neurological Disease Research

--Cardiovascular Disease Research

--Immunological Disease Research

--Others (Genetic Disease Research, Metabolic Disease Research, etc.)

-By Diagnostics

--Oncology Diagnostics

--Infectious Diseases Diagnostics

--Neurological Disease Diagnostics

--Cardiovascular Disease Diagnostics

--Others (Genetic Disease Diagnostics, Metabolic Disease Diagnostics, etc.)

By End User

-Hospitals and Diagnostic Laboratories

-Pharmaceutical & Biotechnology Companies

-Contract Research Organizations (CROs)

-Others (Academic and Research Institutions, Specialty Clinics, etc.)

Top leading companies in the Tissue Imaging Market includes:

Abbott Laboratories, Roche Holding AG, Bio-Rad Laboratories, Bio SB, Inc., Agilent Technologies, Olympus Corporation, Abcam Plc, Biocare Medical LLC, Sakura Finetek., LifeSpan BioSciences, Inc., Hamamatsu Photonics K.K., Danaher Corporation, Merck KGaA., Thermo Fisher Scientific Inc., Becton, and Dickinson

Tissue Imaging Market Development

• 2024: Roche Holding AG received the US FDA clearance for its whole-slide imaging system, the Roche Digital Pathology Dx, for use as an aid in clinical diagnosis. This system would help pathologists review and interpret digital images of scanned pathology slides.
• 2024: Bio-Rad launched ChemiDoc Go Imaging System for highly sensitive benchtop gel and Western blot imaging.

For more detailed information about the Tissue Imaging market report, click here – https://www.marknteladvisors.com/research-library/global-tissue-imaging-market.html          

Geographical analysis:

North America: The US, Canada, Mexico

Europe: Germany, Germany, The UK, France, Italy, Spain, Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia Pacific

South America: Brazil, Argentina, Rest of South America

Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of the Middle East & Africa

• North America is anticipated to hold the highest market share among all the regions in 2030.

Related Reports: -

https://www.openpr.com/news/3396952/global-workplace-safety-market-reach-usd-14-9-billion-in-2023         

https://www.openpr.com/news/3391034/global-pea-protein-market-size-hits-usd-1-4-billion-mark-in-2022         

https://www.openpr.com/news/3391023/global-green-hydrogen-market-expected-to-witness-a-15-7-cagr  

Why choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India